NCT01631552: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
- State
- Completed
- Phase
- Phase 1 and Phase 2
- People
- 515 taking part
- Started
- 17 Dec 2012
- Primary completion
- 1 Mar 2019
- Arms
- Sacituzumab Govitecan-hziy (SG) 8 mg/kg, SG 10 mg/kg, SG 12 mg/kg, SG 18 mg/kg
- Results
- Posted on the registry
- 29 Jun 2012: Trial registered
- 17 Dec 2012: Trial started
- 13 Aug 2020: Trial completed
- 6 Apr 2021: Trial results posted